BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34327853)

  • 1. The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients.
    Liao CT; Huang JL; Liang HW; Chung FP; Lee YH; Lin PL; Chiou WR; Lin WY; Hsu CY; Chang HY
    ESC Heart Fail; 2021 Oct; 8(5):4199-4210. PubMed ID: 34327853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiating ivabradine during hospitalization in patients with acute heart failure: A real-world experience in China.
    Liu YX; Chen W; Lin X; Zhu YL; Lai JZ; Li JY; Guo XX; Yang J; Qian H; Zhu YY; Wu W; Fang LG
    Clin Cardiol; 2022 Sep; 45(9):928-935. PubMed ID: 35870176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
    Bryan Richard S; Huang B; Liu G; Yang Y; Luo S
    Clin Cardiol; 2021 Apr; 44(4):463-471. PubMed ID: 33638556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the applicability of ivabradine in acute heart failure.
    Tsai TH; Tsai ML; Chen DY; Lin Y; Peng JR; Yang NI; Hung MJ; Chen TH
    Clin Cardiol; 2024 Jan; 47(1):e24206. PubMed ID: 38269634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
    Bouabdallaoui N; O'Meara E; Bernier V; Komajda M; Swedberg K; Tavazzi L; Borer JS; Bohm M; Ford I; Tardif JC
    ESC Heart Fail; 2019 Dec; 6(6):1199-1207. PubMed ID: 31591826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
    Böhm M; Abdin A; Slawik J; Mahfoud F; Borer J; Ford I; Swedberg K; Tavazzi L; Batailler C; Komajda M
    Eur J Heart Fail; 2023 Aug; 25(8):1429-1435. PubMed ID: 37092340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ivabradine in heart failure: a meta-analysis of heart failure patients with reduced versus preserved ejection fraction.
    Tóth N; Soós A; Váradi A; Hegyi P; Tinusz B; Vágvölgyi A; Orosz A; Solymár M; Polyák A; Varró A; Farkas AS; Nagy N
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1159-1174. PubMed ID: 34636643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Ivabradine on Hospitalization of Heart Failure Patients: A Retrospective Cohort Study.
    Al-Balushi S; Alam MF; Abid AR; Sharfi A
    Heart Views; 2021; 22(3):165-173. PubMed ID: 34760047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine for treatment of heart failure.
    Bocchi EA; Salemi VMC
    Expert Opin Drug Saf; 2019 May; 18(5):393-402. PubMed ID: 31074301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation.
    Lin YS; Jan JY; Chang JJ; Lin MS; Yang TY; Wang PC; Chen MC
    ESC Heart Fail; 2022 Aug; 9(4):2548-2557. PubMed ID: 35560828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
    Guzman M; Gomez R; Romero SP; Aranda R; Andrey JL; Pedrosa MJ; Egido J; Gomez F
    Int J Clin Pract; 2018 Nov; 72(11):e13217. PubMed ID: 30248211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
    Hidalgo FJ; Anguita M; Castillo JC; Rodríguez S; Pardo L; Durán E; Sánchez JJ; Ferreiro C; Pan M; Mesa D; Delgado M; Ruiz M
    Int J Cardiol; 2016 Aug; 217():7-11. PubMed ID: 27167103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study.
    Tsutsui H; Momomura SI; Yamashina A; Shimokawa H; Kihara Y; Saito Y; Hagiwara N; Ito H; Yano M; Yamamoto K; Ako J; Inomata T; Sakata Y; Tanaka T; Kawasaki Y;
    Circ J; 2019 Sep; 83(10):2049-2060. PubMed ID: 31391387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early administration of ivabradine in patients admitted for acute decompensated heart failure.
    Yang TY; Tsai MS; Jan JY; Chang JJ; Chung CM; Lin MS; Chen HM; Lin YS
    Front Cardiovasc Med; 2022; 9():1036418. PubMed ID: 36523364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
    Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
    ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.